Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.58% |
| 2 | Energy | 11.62% |
| 3 | Consumer Discretionary | 8.89% |
| 4 | Financials | 8.63% |
| 5 | Technology | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
BlackRock TCP Capital
TCPC
$351M
| $636K | ﹤0.01% |
+46,932
| New | +$716K |
|
|
MRTX
2527
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $636K | ﹤0.01% |
+18,472
| New | +$558K |
|
2528
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$3.04B
| $635K | ﹤0.01% |
+76,556
| New | +$720K |
|
2529
Argan
AGX
$6.32B
| $633K | ﹤0.01% |
18,253
-14,874
| -45% | -$572K |
|
2530
City Holding Co
CHCO
$2.03B
| $633K | ﹤0.01% |
12,848
+2,669
| +26% | +$130K |
|
2531
T. Rowe Price
TROW
$24.1B
| $633K | ﹤0.01% |
9,102
-544,933
| -98% | -$40.4M |
|
2532
Avient
AVNT
$4.09B
| $632K | ﹤0.01% |
21,534
-32,406
| -60% | -$1.1M |
|
|
BZUN
2533
Baozun
BZUN
$165M
| $632K | ﹤0.01% |
131,031
-76,556
| -37% | -$522K |
|
|
FOGO
2534
DELISTED
Fogo de Chao, Inc. Common Stock
FOGO
| $632K | ﹤0.01% |
40,539
-66,981
| -62% | -$1.31M |
|
|
ZPIN
2535
DELISTED
Zhaopin Limited
ZPIN
| $632K | ﹤0.01% |
49,006
-20,439
| -29% | -$281K |
|
2536
Horizon Technology Finance
HRZN
$320M
| $631K | ﹤0.01% |
69,686
+47,885
| +220% | +$516K |
|
|
GPL
2537
DELISTED
Great Panther Mining Limited
GPL
| $631K | ﹤0.01% |
160,444
-16,387
| -9% | -$63.8K |
|
2538
Zevra Therapeutics
ZVRA
$715M
| $629K | ﹤0.01% |
+2,029
| New | +$621K |
|
2539
Mercury Insurance
MCY
$5.79B
| $628K | ﹤0.01% |
+12,429
| New | +$666K |
|
|
LDL
2540
DELISTED
Lydall, Inc.
LDL
| $625K | ﹤0.01% |
+21,949
| New | +$627K |
|
2541
Middlesex Water
MSEX
$1.11B
| $623K | ﹤0.01% |
26,120
+16,505
| +172% | +$379K |
|
2542
Annaly Capital Management
NLY
$17.4B
| $621K | ﹤0.01% |
15,718
-190,257
| -92% | -$7.61M |
|
|
TESS
2543
DELISTED
Tessco Technologies Inc
TESS
| $621K | ﹤0.01% |
29,496
+8,607
| +41% | +$193K |
|
2544
Ardelyx
ARDX
$976M
| $620K | ﹤0.01% |
35,894
-131,514
| -79% | -$2.45M |
|
|
CSII
2545
DELISTED
Cardiovascular Systems, Inc.
CSII
| $618K | ﹤0.01% |
38,985
-218,304
| -85% | -$5.5M |
|
|
ALTA
2546
DELISTED
Altabancorp
ALTA
| $618K | ﹤0.01% |
37,883
+20,782
| +122% | +$352K |
|
|
MASI
2547
DELISTED
Masimo
MASI
| $615K | ﹤0.01% |
15,944
-4,691
| -23% | -$192K |
|
2548
Independent Bank Corp
IBCP
$815M
| $613K | ﹤0.01% |
41,500
+19,856
| +92% | +$280K |
|
2549
B2Gold
BTG
$7.75B
| $611K | ﹤0.01% |
582,380
+349,440
| +150% | +$425K |
|
|
THR
2550
DELISTED
Thermon Group Holdings
THR
| $609K | ﹤0.01% |
29,634
-18,193
| -38% | -$421K |
|
Similar funds
Israel Englander's Q3 2015 Portfolio in Review
As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander deployed $5.12B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Israel Englander opened 839 new positions and closed 681 in Q3 2015.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.